TP53 status and response to treatment in breast cancers. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Biomedicine and Biotechnology Année : 2011

TP53 status and response to treatment in breast cancers.

Résumé

The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is reported to be a factor for good prognosis in some studies, while in others it is a factor for poor prognosis. The explanation for these different results could be linked to the fact that the studies were performed on different tumor types and with different therapy regimens.

Domaines

Cancer
Fichier principal
Vignette du fichier
284584.pdf (1.14 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-00741097 , version 1 (11-10-2012)

Identifiants

Citer

Mariana Varna, Guilhem Bousquet, Louis-François Plassa, Philippe Bertheau, Anne Janin. TP53 status and response to treatment in breast cancers.. Journal of Biomedicine and Biotechnology, 2011, 2011, pp.284584. ⟨10.1155/2011/284584⟩. ⟨inserm-00741097⟩

Collections

INSERM UNIV-PARIS7
141 Consultations
178 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More